All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
08Jul21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Allergy Therapeutics - Trading Update
01Jun21 15:36 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Allergy Therapeutics - Total Voting Rights
06May21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Completion of treatment phase in G309 study
30Apr21 17:47 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Total Voting Rights
16Apr21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Appointment of new Group auditors
31Mar21 08:29 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Pledge of Shares
11Mar21 12:13 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Pledge of Shares
08Mar21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Initiation of peanut allergy biomarker study
14Dec20 15:58 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
08Dec20 14:42 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Result of Annual General Meeting
20Nov20 13:51 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
10Nov20 07:05 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Annual Report & Accounts and AGM Notification
26Oct20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
09Oct20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director Dealings and Issue of Equity
23Sep20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Preliminary Results
03Sep20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m AGY secures VLP technology platform
20Jul20 07:30 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update
09Jul20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Total Voting Rights
24Jun20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update
22Apr20 10:11 RNS-R AGY:LON Allergy Therapeutics plc Health £143.0m EAACI review of adjuvants and formulations
01Apr20 13:09 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Grant and Vesting of Awards
09Mar20 07:15 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Half-year Report
29Jan20 12:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Data for peanut allergy vaccine published in JACI
16Jan20 12:25 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Half Year Trading Update & Notice of Results
02Dec19 09:57 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
29Nov19 10:34 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
26Nov19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Result of Annual General Meeting
22Oct19 09:23 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Annual Report and Accounts
26Sep19 07:30 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Preliminary Results
11Jul19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading update
01Jul19 07:21 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Successful Litigation Settlement
27Jun19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Statement
19Jun19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Board Change
11Jun19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
21May19 08:30 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Titon Holdings Plc (TON): You need hands
21May19 07:15 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress
20May19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Positive top line phase I results for Acarovac MPL
14May19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
13May19 18:14 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
07May19 07:00 RNS-R AGY:LON Allergy Therapeutics plc Health £143.0m Research Published on Adjuvant Systems
25Apr19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Regulatory and Trading Update
18Mar19 11:30 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view
18Mar19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Top Line Phase III results from B301 trial
06Mar19 12:10 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share
06Mar19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Interim Results
17Jan19 09:56 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
16Jan19 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update & Notice of Results
29Nov18 17:59 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
27Nov18 13:12 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Result of AGM
27Nov18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m AGM Trading Update
12Nov18 12:00 RNS-R AGY:LON Allergy Therapeutics plc Health £143.0m Presentation at Jefferies Healthcare Conference
08Nov18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Directorate Change
07Nov18 18:06 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
02Nov18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Grant of Awards under Long Term Incentive Plan
24Oct18 13:25 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
24Oct18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
23Oct18 17:29 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Annual Report and Accounts
23Oct18 15:28 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
27Sep18 07:15 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth
08Aug18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Notice of Results
27Jul18 17:26 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
26Jul18 12:02 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
19Jul18 10:19 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Results of Placing and Subscription
19Jul18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Proposed placing & subscription to raise £10.6m
13Jul18 09:40 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
12Jul18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update
21May18 12:25 EQS AGY:LON Allergy Therapeutics plc Health £143.0m Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration
21May18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Positive top-line results from Grass Ph II study
16Mar18 15:38 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Grant of Awards under Long Term Incentive Plan
16Mar18 12:53 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
07Mar18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Interim Results
28Feb18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Polyvac® Peanut CMO appointed
12Feb18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Completion of recruitment in PQ Grass Ph II trial
31Jan18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Trading Update
10Jan18 15:19 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holdings in Company
09Jan18 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m PQ Birch Phase III trial completes recruitment
07Dec17 17:08 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
22Nov17 11:36 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Result of AGM
07Nov17 12:59 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
07Nov17 11:54 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
19Oct17 16:14 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Publication of Annual Report and notice of AGM
19Oct17 07:00 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Commencement of dosing in PQ Grass Phase II Trial
12Oct17 17:39 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Holding(s) in Company
12Oct17 14:55 RNS AGY:LON Allergy Therapeutics plc Health £143.0m Director/PDMR Shareholding
Date / Time Source Company % Chg
08Jul21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update
01Jun21 15:36 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
06May21 07:00 RNS Allergy Therapeutics plc 0.00%
Completion of treatment phase in G309 study
30Apr21 17:47 RNS Allergy Therapeutics plc 0.00%
Total Voting Rights
16Apr21 07:00 RNS Allergy Therapeutics plc 0.00%
Appointment of new Group auditors
31Mar21 08:29 RNS Allergy Therapeutics plc 0.00%
Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 RNS Allergy Therapeutics plc 0.00%
Pledge of Shares
11Mar21 12:13 RNS Allergy Therapeutics plc 0.00%
Pledge of Shares
08Mar21 07:00 RNS Allergy Therapeutics plc 0.00%
AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 RNS Allergy Therapeutics plc 0.00%
Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 RNS Allergy Therapeutics plc 0.00%
Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 RNS Allergy Therapeutics plc 0.00%
Initiation of peanut allergy biomarker study
14Dec20 15:58 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
08Dec20 14:42 RNS Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
20Nov20 13:51 RNS Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
10Nov20 07:05 RNS Allergy Therapeutics plc 0.00%
Annual Report & Accounts and AGM Notification
26Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
09Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Director Dealings and Issue of Equity
23Sep20 07:00 RNS Allergy Therapeutics plc 0.00%
Preliminary Results
03Sep20 07:00 RNS Allergy Therapeutics plc 0.00%
AGY secures VLP technology platform
20Jul20 07:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
09Jul20 07:00 RNS Allergy Therapeutics plc 0.00%
Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 RNS Allergy Therapeutics plc 0.00%
Total Voting Rights
24Jun20 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
22Apr20 10:11 RNS-R Allergy Therapeutics plc 0.00%
EAACI review of adjuvants and formulations
01Apr20 13:09 RNS Allergy Therapeutics plc 0.00%
Grant and Vesting of Awards
09Mar20 07:15 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 RNS Allergy Therapeutics plc 0.00%
Half-year Report
29Jan20 12:00 RNS Allergy Therapeutics plc 0.00%
Data for peanut allergy vaccine published in JACI
16Jan20 12:25 RNS Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS Allergy Therapeutics plc 0.00%
Half Year Trading Update & Notice of Results
02Dec19 09:57 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
29Nov19 10:34 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
26Nov19 07:00 RNS Allergy Therapeutics plc 0.00%
Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 RNS Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
22Oct19 09:23 RNS Allergy Therapeutics plc 0.00%
Annual Report and Accounts
26Sep19 07:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 RNS Allergy Therapeutics plc 0.00%
Preliminary Results
11Jul19 07:00 RNS Allergy Therapeutics plc 0.00%
Trading update
01Jul19 07:21 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Successful Litigation Settlement
27Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Statement
19Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Board Change
11Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
21May19 08:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Titon Holdings Plc (TON): You need hands
21May19 07:15 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress
20May19 07:00 RNS Allergy Therapeutics plc 0.00%
Positive top line phase I results for Acarovac MPL
14May19 07:00 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
13May19 18:14 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
07May19 07:00 RNS-R Allergy Therapeutics plc 0.00%
Research Published on Adjuvant Systems
25Apr19 07:00 RNS Allergy Therapeutics plc 0.00%
Regulatory and Trading Update
18Mar19 11:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view
18Mar19 07:00 RNS Allergy Therapeutics plc 0.00%
Top Line Phase III results from B301 trial
06Mar19 12:10 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share
06Mar19 07:00 RNS Allergy Therapeutics plc 0.00%
Interim Results
17Jan19 09:56 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
16Jan19 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results
29Nov18 17:59 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
27Nov18 13:12 RNS Allergy Therapeutics plc 0.00%
Result of AGM
27Nov18 07:00 RNS Allergy Therapeutics plc 0.00%
AGM Trading Update
12Nov18 12:00 RNS-R Allergy Therapeutics plc 0.00%
Presentation at Jefferies Healthcare Conference
08Nov18 07:00 RNS Allergy Therapeutics plc 0.00%
Directorate Change
07Nov18 18:06 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
02Nov18 07:00 RNS Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
24Oct18 13:25 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
24Oct18 07:00 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
23Oct18 17:29 RNS Allergy Therapeutics plc 0.00%
Annual Report and Accounts
23Oct18 15:28 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
27Sep18 07:15 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth
08Aug18 07:00 RNS Allergy Therapeutics plc 0.00%
Notice of Results
27Jul18 17:26 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
26Jul18 12:02 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
19Jul18 10:19 RNS Allergy Therapeutics plc 0.00%
Results of Placing and Subscription
19Jul18 07:00 RNS Allergy Therapeutics plc 0.00%
Proposed placing & subscription to raise £10.6m
13Jul18 09:40 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
12Jul18 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
21May18 12:25 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration
21May18 07:00 RNS Allergy Therapeutics plc 0.00%
Positive top-line results from Grass Ph II study
16Mar18 15:38 RNS Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
16Mar18 12:53 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
07Mar18 07:00 RNS Allergy Therapeutics plc 0.00%
Interim Results
28Feb18 07:00 RNS Allergy Therapeutics plc 0.00%
Polyvac® Peanut CMO appointed
12Feb18 07:00 RNS Allergy Therapeutics plc 0.00%
Completion of recruitment in PQ Grass Ph II trial
31Jan18 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
10Jan18 15:19 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
09Jan18 07:00 RNS Allergy Therapeutics plc 0.00%
PQ Birch Phase III trial completes recruitment
07Dec17 17:08 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
22Nov17 11:36 RNS Allergy Therapeutics plc 0.00%
Result of AGM
07Nov17 12:59 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
07Nov17 11:54 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
19Oct17 16:14 RNS Allergy Therapeutics plc 0.00%
Publication of Annual Report and notice of AGM
19Oct17 07:00 RNS Allergy Therapeutics plc 0.00%
Commencement of dosing in PQ Grass Phase II Trial
12Oct17 17:39 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
12Oct17 14:55 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
Date / Time Company % Chg
08Jul21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update
01Jun21 15:36 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
06May21 07:00 Allergy Therapeutics plc 0.00%
Completion of treatment phase in G309 study
30Apr21 17:47 Allergy Therapeutics plc 0.00%
Total Voting Rights
16Apr21 07:00 Allergy Therapeutics plc 0.00%
Appointment of new Group auditors
31Mar21 08:29 Allergy Therapeutics plc 0.00%
Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 Allergy Therapeutics plc 0.00%
Pledge of Shares
11Mar21 12:13 Allergy Therapeutics plc 0.00%
Pledge of Shares
08Mar21 07:00 Allergy Therapeutics plc 0.00%
AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 Allergy Therapeutics plc 0.00%
Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 Allergy Therapeutics plc 0.00%
Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 Allergy Therapeutics plc 0.00%
Initiation of peanut allergy biomarker study
14Dec20 15:58 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
08Dec20 14:42 Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
20Nov20 13:51 Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
10Nov20 07:05 Allergy Therapeutics plc 0.00%
Annual Report & Accounts and AGM Notification
26Oct20 07:00 Allergy Therapeutics plc 0.00%
Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 Allergy Therapeutics plc 0.00%
Holding(s) in Company
09Oct20 07:00 Allergy Therapeutics plc 0.00%
Director Dealings and Issue of Equity
23Sep20 07:00 Allergy Therapeutics plc 0.00%
Preliminary Results
03Sep20 07:00 Allergy Therapeutics plc 0.00%
AGY secures VLP technology platform
20Jul20 07:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 Allergy Therapeutics plc 0.00%
Trading Update
09Jul20 07:00 Allergy Therapeutics plc 0.00%
Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 Allergy Therapeutics plc 0.00%
Total Voting Rights
24Jun20 07:00 Allergy Therapeutics plc 0.00%
Trading Update
22Apr20 10:11 Allergy Therapeutics plc 0.00%
EAACI review of adjuvants and formulations
01Apr20 13:09 Allergy Therapeutics plc 0.00%
Grant and Vesting of Awards
09Mar20 07:15 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 Allergy Therapeutics plc 0.00%
Half-year Report
29Jan20 12:00 Allergy Therapeutics plc 0.00%
Data for peanut allergy vaccine published in JACI
16Jan20 12:25 Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results - Replacement
16Jan20 08:00 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 Allergy Therapeutics plc 0.00%
Half Year Trading Update & Notice of Results
02Dec19 09:57 Allergy Therapeutics plc 0.00%
Holdings in Company
29Nov19 10:34 Allergy Therapeutics plc 0.00%
Holdings in Company
26Nov19 07:00 Allergy Therapeutics plc 0.00%
Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
22Oct19 09:23 Allergy Therapeutics plc 0.00%
Annual Report and Accounts
26Sep19 07:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 Allergy Therapeutics plc 0.00%
Preliminary Results
11Jul19 07:00 Allergy Therapeutics plc 0.00%
Trading update
01Jul19 07:21 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 Allergy Therapeutics plc 0.00%
Successful Litigation Settlement
27Jun19 07:00 Allergy Therapeutics plc 0.00%
Trading Statement
19Jun19 07:00 Allergy Therapeutics plc 0.00%
Board Change
11Jun19 07:00 Allergy Therapeutics plc 0.00%
Holdings in Company
21May19 08:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Titon Holdings Plc (TON): You need hands
21May19 07:15 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress
20May19 07:00 Allergy Therapeutics plc 0.00%
Positive top line phase I results for Acarovac MPL
14May19 07:00 Allergy Therapeutics plc 0.00%
Holdings in Company
13May19 18:14 Allergy Therapeutics plc 0.00%
Holding(s) in Company
07May19 07:00 Allergy Therapeutics plc 0.00%
Research Published on Adjuvant Systems
25Apr19 07:00 Allergy Therapeutics plc 0.00%
Regulatory and Trading Update
18Mar19 11:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view
18Mar19 07:00 Allergy Therapeutics plc 0.00%
Top Line Phase III results from B301 trial
06Mar19 12:10 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share
06Mar19 07:00 Allergy Therapeutics plc 0.00%
Interim Results
17Jan19 09:56 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
16Jan19 07:00 Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results
29Nov18 17:59 Allergy Therapeutics plc 0.00%
Holdings in Company
27Nov18 13:12 Allergy Therapeutics plc 0.00%
Result of AGM
27Nov18 07:00 Allergy Therapeutics plc 0.00%
AGM Trading Update
12Nov18 12:00 Allergy Therapeutics plc 0.00%
Presentation at Jefferies Healthcare Conference
08Nov18 07:00 Allergy Therapeutics plc 0.00%
Directorate Change
07Nov18 18:06 Allergy Therapeutics plc 0.00%
Holdings in Company
02Nov18 07:00 Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
24Oct18 13:25 Allergy Therapeutics plc 0.00%
Holdings in Company
24Oct18 07:00 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
23Oct18 17:29 Allergy Therapeutics plc 0.00%
Annual Report and Accounts
23Oct18 15:28 Allergy Therapeutics plc 0.00%
Holdings in Company
27Sep18 07:15 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth
08Aug18 07:00 Allergy Therapeutics plc 0.00%
Notice of Results
27Jul18 17:26 Allergy Therapeutics plc 0.00%
Holding(s) in Company
26Jul18 12:02 Allergy Therapeutics plc 0.00%
Holding(s) in Company
19Jul18 10:19 Allergy Therapeutics plc 0.00%
Results of Placing and Subscription
19Jul18 07:00 Allergy Therapeutics plc 0.00%
Proposed placing & subscription to raise £10.6m
13Jul18 09:40 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
12Jul18 07:00 Allergy Therapeutics plc 0.00%
Trading Update
21May18 12:25 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration
21May18 07:00 Allergy Therapeutics plc 0.00%
Positive top-line results from Grass Ph II study
16Mar18 15:38 Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
16Mar18 12:53 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
07Mar18 07:00 Allergy Therapeutics plc 0.00%
Interim Results
28Feb18 07:00 Allergy Therapeutics plc 0.00%
Polyvac® Peanut CMO appointed
12Feb18 07:00 Allergy Therapeutics plc 0.00%
Completion of recruitment in PQ Grass Ph II trial
31Jan18 07:00 Allergy Therapeutics plc 0.00%
Trading Update
10Jan18 15:19 Allergy Therapeutics plc 0.00%
Holdings in Company
09Jan18 07:00 Allergy Therapeutics plc 0.00%
PQ Birch Phase III trial completes recruitment
07Dec17 17:08 Allergy Therapeutics plc 0.00%
Holding(s) in Company
22Nov17 11:36 Allergy Therapeutics plc 0.00%
Result of AGM
07Nov17 12:59 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
07Nov17 11:54 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
19Oct17 16:14 Allergy Therapeutics plc 0.00%
Publication of Annual Report and notice of AGM
19Oct17 07:00 Allergy Therapeutics plc 0.00%
Commencement of dosing in PQ Grass Phase II Trial
12Oct17 17:39 Allergy Therapeutics plc 0.00%
Holding(s) in Company
12Oct17 14:55 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding